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Abstract.  Cell shape changes exert specific effects on 
gene expression.  It has been speculated that the cyto- 
skeleton is responsible for converting changes in the 
cytoarchitecture to effects on gene transcription.  How- 
ever,  the signal transduction pathways responsible for 
cytoskeletal-nuclear communication remained un- 
known. We now provide evidence that a variety of 
agents and conditions that depolymerize microtubules 
activate the sequence-specific transcription  factor 
NF-xB and induce NFKB-dependent gene expression. 
These effects are caused by depolymerization of micro- 
tubule because they are blocked by the microtubule- 
stabilizing agent taxol.  In nonstimulated cells, the 
majority of NF-xB resides in the cytosplasm as a 
complex with its inhibitor IxB.  Upon cell stimulation, 
NF-KB translocates to the nucleus with concomitant 
degradation of IKB. We show that cold-induced de- 
polymerization of microtubules also leads to IKB deg- 
radation and activation of NF-~B.  However, the acti- 
vated factor remains in the cytoplasm and translocates 
to the nucleus only upon warming to 37°C,  thus re- 
vealing two distinct steps in NF-KB activation.  These 
findings establish a new role for NF-KB in sensing 
changes in the state of the cytoskeleton and converting 
them to changes in gene activity. 
variety of observations suggest  that  changes  in cell 
shape or architecture  can regulate gene expression 
(6, 35). The shape of a cell is affected by interactions 
with either  the extracellular  matrix  or neighboring  cells, 
which lead to restructuring  of the cytoplasmic cytoskeleton. 
Altering cytoskeletal structure may in turn change the avail- 
ability of regulatory or catalytic sites of key signal-trans- 
ducing molecules.  Some of the classical  examples illustrat- 
ing  the  effect  of  cell  shape  changes  on  nuclear  gene 
expression  include a switch from type I to type II collagen 
expression  by condriocytes upon a  shift  from  growth  on 
fibronectin to growth in suspension (7), as well as the repres- 
sion of liver-specific  gene expression  in dispersed hepato- 
cytes and its resumption upon cell aggregation (14). The ex- 
act mechanisms by which changes in cell shape are converted 
to changes in the pattern of gene expression  have not been 
explained,  but the cytoskeleton is a good candidate  to have 
a key role in this mysterious signal transduction  process. It 
has been suggested that the cytoskeleton may regulate gene 
expression  by interacting  with the nuclear matrix  (9),  and 
that this interaction  may lead to physical  expansion  of nu- 
clear pores and thereby increase the rate of nuclear transport 
in spreading  cells (35). 
One of the major components of the cytoskeleton is the 
microtubule network.  Because of the dynamic instability  of 
tubulin dimers,  this structure is subject to constant remodel- 
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ing. Massive microtubule reorganization  occurs in the mi- 
totic phase of the cell cycle (46),  during cell differentiation 
(36), upon specific binding of cytotoxic T lymphocytes to its 
target cell (24), and during injury-induced  migration  of en- 
dothelial cells to wounded tissue (27). This massive microtu- 
bule reorganization  correlates with changes in gene expres- 
sion.  Depolymerization  of microtubules  with  drugs  can 
stimulate  cell proliferation  in the absence of other signals 
(15), whereas stabilization  of microtubules can inhibit  the 
action  of certain  mitogens  (16).  It  was  shown  that  tran- 
scription  of several  genes,  including  the ones that  encode 
urokinase  type plasminogen  activator (uPA)'  (11, 38) and 
interleukin  IL-lfl  (23, 44)  is  activated  by  microtubule- 
depolymerizing  agents such as nocodazole and colchicine. 
One plausible way by which the cytoplasmic cytoskeleton 
can affect nuclear gene expression is by modulating the activ- 
ity of transcription  factors that reside in the cytoplasm of un- 
stimulated  cells in an inactive form and migrate  to the nu- 
cleus in response to various  stimuli  (34).  Such factors are 
the  NF-KBs, a  collection of structurally  and  functionally 
related dimeric complexes that activate transcription  of im- 
munoregulatory genes that  encode cell surface receptors, 
cytokines, acute phase reactants,  and cell adhesion  mole- 
cules  (reviewed  in  reference  28).  NF-rB  was  originally 
characterized  as a heterodimer of two subunits, p50 and p65, 
each of which is also capable of  homodimerizing  and binding 
1. Abbreviations used in this paper: CAT, chloramphenicoI acetyl transfer- 
ase; TPA, tetradecanoyl phorbol acetate; uPA, urokinase plasminogen acti- 
vator. 
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consists of multiple dimer-forming proteins with homology 
to  the tel oncogene  (28).  The  cellular  localization,  DNA 
binding, and transcriptional properties of the NF-KB proteins 
are regulated by a second family of proteins, the IKBs, that 
contain ankyrin-type repeats (10, 26, 41).  The ankyrin-type 
repeats of ankyrins are thought to form binding sites for inte- 
gral membrane proteins and tubulin (17, 43). It was proposed 
that IrB  prevents NF-KB  nuclear translocation by masking 
the nuclear localization  signal located in the Rel homology 
domain common to these proteins (5,  62).  This interaction 
is  mediated  through the  ankyrin-type  repeats  of IrB  (31). 
However, it is also possible that the ankyrin-type repeats of 
IKB  may  make  additional  contribution to  the  cytoplasmic 
retention of NF-rB through an interaction with cytoskeletal 
components.  This may allow the activity  state of NF-rB to 
be modulated by the cytoarchitecture and provide a mecha- 
nism for gene regulation in response to cytoskeletal changes. 
In this paper, we demonstrate that microtuhule depolymer- 
ization can lead to activation of NF-KB- and NF-KB-depen- 
dent gene expression. These findings establish a signal trans- 
duction  pathway  that  interprets  changes  in  the  state  of the 
cytoplasmic  cytoskeleton  and converts them to changes in 
the activity  of a sequence-specific  transcription  factor. 
Materials and Methods 
Reagents 
TPA (stored at 100 ng/#l in ethanol), nocodazole (4 mg/ml in DMSO), col- 
chicine (0.4 mg/ml in DMSO), vinblastine  (10 mg/mi in ethanol), podophyl- 
lotoxin (50 #g/ml in PBS), taxol (10 mM in DMSO), ~-lumicolchicine  (0.4 
mg/ml in DMSO), cytochalasin D (1 mg/ml in DMSO), cyclobeximide (10 
#tg in PBS), and monoclonal anti-{/-tubulin  (mAb TUB2.1) were purchased 
from Sigma Chemical Co. (St. Louis,  MO). Rabbit anti-pS0 antibody was 
generated against a  synthetic  NH2-terminal  peptide  (MAEDDPYLGR- 
PEQK),  rabbit anti-p65  antibody was generated against recombinant p65 
(45),  and rabbit anti-IKBc~  was generated against  recombinant IKBc~ (21). 
Cell Culture and Transfection 
HeLa $3 cells were maintained in DME supplemented with 10% FBS, 2 
mM glutamine, 100 U/ml penicillin and 100 #g/ml streptomycin.  FOr in- 
duction experiments,  cells were incubated with DME containing 0.5 % FBS 
for 24 h and then treated with the different agents for the indicated time 
periods.  Human peripheral blood mononuclear cells prepared from whole 
heparinized  blood by density-gradient centrifugation  on Ficoll-Paque  (Phar- 
macia Fine Chemicals, Piscataway, NJ) were enriched in monocytes by ad- 
herence to plastic tissue culture plates for 4 h at 37°C in RPMI containing 
3 % human serum. Nonadherent cells were removed by washing with media 
and then treated with the different  agents.  FOr transfection experiments, 
cells were fed with fresh medium containing 10% FBS 3 h before incubation 
with calcium phosphate-DNA precipitate containing 2xKB-CAT (5  /~g). 
2xn~B-CAT (5 #g), or -73 Col-CAT (2 pg). Each 100-ram culture dish was 
transfected  with a  total  DNA  amount adjusted  to  I0  #g  with pUC18. 
Precipitates were left on cells for 4 h before shocking with 10% glycerol 
for 3 min. Cells were washed twice with PBS and then refed with DME 
containing  0.5 % FBS. Treatments with tetradecanoyl phorbol acetate (TPA) 
(100 ng/ml) or nocodazole  (0.4/~g/ml)  were initiated 24 h later. The cells 
were harvested after a  12-h induction period. Extracts  were prepared by 
sonicating,  and chloramphenicol acetyl transferase (CAT) enzyme activity 
was determined as described (2). 
Preparation of  CeU Extracts, Mobility Shift Assays, 
and Immunoblotting 
Cells were washed twice with PBS and then scraped off  the plate with a rub- 
ber policeman. For preparation of whole cell extracts,  cell pellets were 
resuspended  in high salt buffer C  (20 mM Hepes,  pH 7.9, 0.4 M NaCI, 
1 ram EDTA, 1 mM DTT, 0.5 mM PMSE 2.5/~g/mi aprotinin, 2.5/~g/ml 
leupeptin, 1/~g/ml bestatin, and 1/~g/nd pepstatin) containing  0.02 % NP-40 
and rotated at 4°C for 30 rain. Particulate material was removed by centrifu- 
gation at 10,000 g for 5 rain. For preparation of cytoplasmic  and nuclear 
extracts, cell pellets were resnspended in bypotonic buffer A (10 mM Hepes, 
pH 7.9, 10 mM KCI, 0.2 mM EDTA, 0.1 mM EGTA,  1 mM DTT, and pro- 
tease inhibitors as indicated above), and they were allowed to swell on ice 
for 15 rain. NP-40  was added to 0.02%,  and the suspension was passed 
six times through a 26.5-gauge needle.  Nuclei  were pelleted  for 1 min at 
10,000 g, and the supernatant  was recovered as the cytoplasmic extract. The 
nuclear pellet was resuspended  in buffer C and rotated at 4°C for 30 rain. 
Particulate material was pelleted,  and the supernatant was recovered as de- 
scribed above. For the mobility shift assays, protein-DNA complexes were 
formed at 4°C for 30 rain in 20 or 30 #1 of 12 mM Hepes,  pH 7.9, 4 mM 
Tris-HC1, pH 7.9, 60 mM KCI, 30 mM NaCI,  5 mM MgCI2, 5 mM DTT, 
0.1 mM EDTA,  12.5% glycerol containing 5/~g poly(dI-dC),  and 0.05 ng 
of 32P-labeled DNA probe (,'~10,000 cpm). The oligonucleotide  sequences 
are as follows: 
PD  5'-TCGAGCGGCAGGGGAATTCCCCTCTCC-  3' 
3'  -CGCCGTCCCCTTAAGGGGAGAGGAGCT-  5' 
Col-TRE  5'  -AGCTTAAAGCATGAGTCAGACACCT-  3' 
3'  - ATTTCGTACTCAGTCTGTGGACTTAA-  5' 
Sp-1  5'-CGATCGGGGCGGGGCGCGATCGGGGCGGGGCG-  3' 
3'-GCTAGCCCCGCCCCGCGCTAGCCCCGCCCCGC-  5' 
KB-ILI#  5"  -AGCTTGAGACTCATGGGAAAATCCCACATTTGAT-  3' 
3'-  CTCTGAGTACCCTTTTAGGGTGTAAACTATTCGA-  5' 
To determine the binding specificity and nature of the complexes,  cold 
oligonucleotides  or antibodies were preincubated with the extracts  for 30 
rain at 4°C  before  incubation with the reaction cocktail containing the 
probe. Protein-DNA complexes were resolved on 5 % or 6% nondenaturing 
polyacrylamide  gels (acrylamide/bisacrylamide  ratio  --  29:1) containing 
0.25x  TBE buffer at 200 V for 2 h at room temperature. 
To detect IrBc~, 10-20 p.g cytoplasmic or whole-cell  extracts were sepa- 
rated on 12 % SDS-polyacrylamide  gel, transferred to a polyvinyldifluoride 
membrane (Millipore Corp., Bedford,  MA) for 3 h in buffer containing 25 
mM Tris base, 200 mM glycine,  and 15% methanol, then blocked in 5% 
dry nonfat milk in PBS for 2-12 h, and then incubated in rabbit polycional 
antibody to IKBc~, followed by anti-rabbit  IgG coupled to horseradish perox- 
idase (Amersham Corp.,  Arlington Heights,  IL). Immunoreactive bands 
were detected  with the ECL chemiluminescent kit (Amersham). 
Preparation of dimeric and polymeric fractions of tubulin was described 
as in (40).  Briefly, dimeric fractions were collected using lysis buffer con- 
taining 80 mM Pipes-KOH,  pH 6.8, 1 mM MgCIz,  2 mM EGTA,  0.5% 
Triton X-100, and polymeric fractions were extracted  from the remaining 
Triton-insoluble  material with 1% SDS in water. Extracts were analyzed by 
immunoblotting with anti-/~-tubulin,  and immunoreactive bands were de- 
tected as above. Chemiluminescence from each band was qnantitated after 
pbosphorimaging in a molecular imaging system (GS-250; Bio Rad Labora- 
tories, Hercules,  CA). 
Results 
Activation of NF-r~B by Nocodazole 
To investigate whether disruption of the microtubule net- 
work affects NF-KB activity, we treated serum-starved HeLa 
$3 cells with nocodazole, a reversible inhibitor of  tubulin 13o. 
lymerization (18). Nuclear extracts were examined for NF- 
rB-binding activity by a mobility shift assay, using a palin- 
dromic NF-rB-binding  site  (60).  As  shown in Fig.  1 a, 
nocodazole treatment resulted  in rapid  activation of NF- 
KB-binding activity. The time course of NF-KB activation by 
nocodazole lagged the time course of microtubule depoly- 
merization by  15 min, determined either by staining with 
anti-/~-tubulin antibody in indirect immunofluorescence of 
intact cells (data not shown) or by immunoblot analysis of 
dimeric and polymeric tubulin fractions (Fig. 1 b). Although 
considerable depolymerization of  microtubules was detected 
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complex (Fig. 2). The total mount of the p50 homodimer- 
DNA complex was increased approximately threefold by the 
nocodazole treatment.  The anti-p50 antiserum had only a 
small inhibitory effect on the activity of the major nocoda- 
zole-induced DNA-binding species, tentatively assigned as 
the p50/p65 heterodimer. Treatment of the extracts with a 
polyclonal antiserum raised against p65 (45) resulted in par- 
tial inhibition of NF-KB-binding activity without any notice- 
able effect on activity of the p50 homodimer. Although these 
results do not distinguish whether the major (23-fold induc- 
tion) nocodazole-induced binding species is p50/p65,  Rel/ 
p65, or p65 homodimer, the electrophoretic mobility of the 
nocodazole induced complex is identical to that of a phorbol 
ester-(TPA)  induced  NF-rB  complex  (Fig.  3).  Previous 
analysis indicates that the major TPA-inducible binding ac- 
tivity in HeLa cells, to the immunoglobulin kappa enhancer, 
is a p50/p65 heterodimer (21, 29). In addition, p65 homo- 
dimers bind rather inefficiently to the palindromic NF-KB 
probe (60). Therefore, the nocodazole-induced binding ac- 
tivity is most likely the p50/IRi5 heterodimer. Oligonucleo- 
tide  competition experiments confirm that this  activity is 
sequence specific (Fig. 2). Oligonucleotides containing ir- 
relevant binding sites or mutated NF-rB-binding sites did 
not compete (data not shown). The experiment shown in Fig. 
Figure 1. Induction of  NF-KB-binding  activity by nocodazole. After 
serum starvation for 24 h,  HeLa $3 cells were treated with 0.4 
/~g/ml noeodazole for 15-120 rain before harvesting and prepara- 
tion of whole-cell extracts or Triton-soluble and-insoluble frac- 
tions. (a) 5-/~g nuclear extracts were used in a mobility shift assay 
with a palindromic NF-~B-binding site as probe. The migration po- 
sitions of  the NF-KB  protein-DNA complex (NF-rdt),  a nonspecific 
pmtein-DNA complex (NS), and the unbound probe (FREE) are 
indicated. (b) Portions of the total Triton-soluble and -insoluble 
fractions  (5%  of each)  were  immunoblotted  with  antibody  to 
fl-tubulin. Lanes 1, 3, 5, and 7were loaded with the Triton-soluble 
fraction, which contains dimeric tubulin, and lanes 2, 4, 6, and 8 
were  loaded with  the  Triton-insoluble fraction,  which contains 
polymeric tubulin. 
within  15 min of exposure to nocodazole, NF-xB-binding 
activity is detectable after 15 min, but it is not maximum un- 
til 30-60 min.  This lag in NF-KB activation suggests that 
microtubule disruption does not directly induce nuclear NF- 
rB-binding activity, but that an intermediate step is neces- 
sary for full activation. 
In addition to the t)50/t)65  NF-KB heterodimer, the palin- 
dromic NF-KB binding site is recognized by the p50 homo- 
dimer and much less efficiently by p65 (60). To investigate 
the nature of the nocodazole-induced NF-KB-binding activ- 
ity,  we used anti-p50 and anti-p65  antibodies.  Incubation 
with a polyclonal antiserum raised against an NH2-terminal 
p50 peptide (45) resulted in complete supershift of a band 
that previously (reference 52 and unpublished results) was 
Figure 2. Characterization of  the nocodazole-induced NF-~B-bind- 
ing activity. Nuclear extracts from untreated (0) or nocodazole- 
(0.4 ~g/ml; 60 rain; N) treated HeLa $3 cells (5-~g samples) were 
used in mobility shift assays with the paiindromic NF-~B site as a 
probe after preincubation with either 2 ~1 of rabbit polyclonal an- 
tisera raised against either an N-terminal p50 peptide (anti-pSO), 
recombinant p65  (anti-p65),  or an NH2-terminal c-jun  peptide 
(anti-dun), 2 ~1 of preimmune rabbit serum, or no additions (con- 
trol).  The uninduced and nocodazole-induced extracts were also 
analyzed in the presence of  25-fold molar excess of  unlabeled palin- 
dromic NF-KB  site (cold PD). The migration positions of  the NF-~B 
protein-DNA  complex (NF-r.B),  the p50 homodimer-DNA com- 
plex, nonspecific protein-DNA complexes (NS), and the unbound 
probe (FREE) are indicated. The upper nonspecific complex (NS) 
is generated by a component of rabbit serum.  The supershifted 
p50-DNA complex is indicated by the arrow. 
Rosette and Karin Activation of NF-rB by Microtubule Depolymerization  1113 Figure 3. NF-xB is specifically activated by nocodazole. Nuclear 
extracts (5 #g) from HeLa $3 cells that were either nontreated (0) 
or treated with either noeodazole (0.4 #g/ml for 60 min; NOC) or 
TPA (100 ng/ml for 60 min; TPA) were analyzed by mobility shift 
assays with probes specific for either NF-xB, Spl, or AP-1. Only the 
segments of each gel that contained the protein-DNA complexes 
are shown in this figure. NS, nonspecific protein-DNA complex. 
3 demonstrates that induction of NF-rB by nocodazole is al- 
most as efficient as its induction by TPA, a well-character- 
ized inducer of NF-rB activity (39). Induction by nocodazole 
is specific to NF-xB since the binding activities of the consti- 
tutive transcription factor Spl  and the TPA-inducible tran- 
scription factor AP-1 were not considerably affected by this 
treatment. 
A  Variety ofMicrotubule DisruptingAgents 
Activate NF-r~B 
To determine whether the induction of NF-KB-binding activ- 
ity by nocodazole is caused by its antimicrotubule activity, 
we  examined  the  effect of several microtubule-disrupting 
agents that have different sites of action on the tubulin dimer 
(42). As shown in Fig. 4 a, treatment with colchicine (CHC), 
podophyllotoxin (PDP), and vinblastine (VSL) led to rapid 
and efficient induction of nuclear NF-KB activity similar to 
nocodazole, whereas the microtubule-stabilizing agent taxol 
(20) or the inactive colchicine analog/3-1umicolchicine (22) 
had no effect. An agent that causes depolymerization of actin 
filaments, cytochalasin D  (61),  did not lead to induction of 
nuclear NF-~B-binding activity. Further proof that the in- 
duction of NF-KB-binding activity is caused by depolymer- 
ization of microtubules is provided by the complete inhibi- 
tion of NF-KB induction by microtubule-disrupting drugs by 
pretreatment of the cells with taxol. As indicated by direct 
Figure  4.  Micrombule  depolymerization  activates  NF-KB. (a) 
Serum-starved HeLa $3 cells were preincubated in the absence (-) 
or in the presence (+) of taxol (5/~g/ml) for 30 rain, followed by 
an additional 60-rain incubation with either nocodazole (blOC; 0.4 
#g/ml),  colchicine (CHC; 40 #g/ml),  podophyHotoxin (PDP; 50 
ng/ml), vinblastine (FBL; 10 #g/ml), TPA (100 ng/ml), O-lumicol- 
chicine (~CHC; 40 #g/rnl), cytochalasin D (CD; 2 #M), or with 
no further additions (CON). 10 #g of nuclear extracts were used 
in a mobility shift assay with the palindromic NF-KB  site as a probe. 
(b)  lO-#g  cytoplasmic  extracts  from the  experiment  described 
above were  immunoblotted  with  anti-IxB~  serum.  The specific 
IxB- band is indicated.  (c) Human peripheral  blood monocytes 
were preincubated  in the absence  or presence  of 5 #g/ml taxol 
(TAX) for 30 rain, followed  by an additional 60-rain incubation with 
40 #g/ml colchicine (CHC), or with no further additions (0). 10-#g 
whole-cell extracts were used in a mobility shift assay with the IL- 
l/3 NF-xB site as probe. 
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also  prevented microtubule depolymerization induced  by 
these drugs (data not shown).  All NF-KB-inducing agents 
analyzed thus far, cause the degradation of IKB (4,  12,  32, 
53, 58). As shown in Fig. 4 b, induction of NF-rB-binding 
activity correlates with the disappearance oflrBa. The level 
of IKBo~ quantitated by phosphorimage analysis of chemilu- 
minescence from each band was reduced by six- and eight- 
fold  below  the  control  value  upon  treatment  with  no- 
codazole and colchicine, respectively. Taxol, however, had 
no effect on induction of  NF-KB activity by TPA. NF-KB acti- 
vation by microtubule disruption is not restricted to HeLa 
cells since binding activity to an oligonucleotide  correspond- 
ing to the NF-rB-binding site located in the IL-1/~ promoter 
is  induced in human  peripheral blood monocytes treated 
with colchicine, and this induction can be blocked with taxol 
(Fig. 4  c). 
Although taxol had no effect on induction of NF-rB activ- 
ity by TPA, downregulation of  protein kinase C by prolonged 
incubation with TPA prevented the induction of NF-rB by a 
second dose of TPA, but had no effect on the response to 
nocodazole (Fig. 5 a). These results suggest that protein ki- 
nase C is not required for induction of NF-rB-binding activ- 
ity by antimicrotubule drugs and that these agents induce 
NF-rB by a different mechanism than TPA. However, a pro- 
tein kinase is involved since the general protein kinase inhib- 
itor, staurosporin, blocked nocodazole-induced NF-KB ac- 
tivity (Fig.  5  b).  As expected, staurosporin also inhibited 
most of the induction response to TPA. 
The  effect of nocodazole on  microtubule  is  reversible 
therefore removal of the drug allows microtubule repolymer- 
ization (19).  Activation of NF-KB is reversed within 15 min 
after removal of the drug unless the protein synthesis inhibi- 
tor cycloheximide was present during the recovery period 
(Fig. 6 a, CHX). As indicated by immunoblot analysis of cy- 
toplasmic extracts with anti-IrBa (Fig. 6 b), the return to 
basal NF-KB-binding activity correlates with the reappear- 
ance of IrB~. The reappearance of IKB is most likely caused 
by  new  synthesis  since  it  is  inhibited  by  cycloheximide. 
These results suggest that inhibition of NF-rB activity after 
repolymerization of microtubules is dependent on the con- 
tinuing synthesis of IrBa. There is a lag in the induction of 
NF-rB by microtubule disruption, but its inhibition is rapid 
after repolymerization. 
Figure 5. Effect of  downregulation of  protein kinase C and a protein 
kinase inhibitor on activation of NF-~B by nocodazole. (a) Serum- 
starved HeLa $3 cells were treated with 100 ng/ml TPA for 24 h 
and then washed twice with PBS to remove TPA. The cells were 
then incubated for an additional 60 rain in fresh medium alone (O), 
or in the presence of 0.4/zg/ml nocodazole (N), or 100 ng/ml TPA 
(T). Nuclear extracts were prepared, and 5-/zg samples were used 
in mobility shift assay with the palindromic NF-~B site as a probe. 
(b) Serum-starved HeLa $3 were incubated for 60 rain in the pres- 
ence or absence of the protein kinase inhibitor staurosporin (150 
nM) without any further treatment or in the presence of either 
noeodazole (NOC; 0.4 tJg/ml) or TPA (100 ng/ml). Nuclear extracts 
were prepared, and 5-/zg  samples were used in a mobility shift assay 
with an NF-rB-specific probe. 
Rosette and Karin  Activation of NF-rB by Microtubule Depolymerization  1115 Figure 6. Microtubule repolymerization reverses NF-rB activation 
by nocodazole. (a) Serum-starved HeLa $3 cells were incubated 
for 30 min in the presence or absence of  the protein synthesis inhib- 
itor cycloheximide (CHX; 10 #M) without any further treatment 
or in the presence of nocodazole (NOC; 0.4 #g/ml) for 60 min. In 
two samples, cells were washed extensively with PBS and then 
replaced in medium containing or lacking cycloheximide  for 15 min 
(NOC + 15'). Nuclear extracts were prepared, and 5-#g samples 
were used in a mobility shift assay with an NF-xB-specific probe. 
(b)  15-tLg cytoplasmic extracts derived from the same cells ana- 
lyzed above were immunoblotted with a polyclonal antiserum to 
IrBc~. The regions of the  autoradiogram  corresponding to the 
specific IgBc~ band is shown, 
Exposure to Low Temperature Reveals Two Steps in 
NF-r~B  Activation 
To examine the effect of micrombule depolymerization on 
NF-KB activity without using pharmacological agents, we in- 
cubated HeLa cells at 4°C for different time periods, and we 
examined the  distribution  of NF-rB-binding  activity be- 
tween the cytosolic and nuclear fractions. Exposure to low 
temperature is known to cause depolymerization of microtu- 
bules (51).  As shown in Fig. 7 a, incubation of HeLa cells 
at 40C for >~1 h elevated NF-KB-binding activity in the cyto- 
plasmic fraction but not in the nuclear fraction. Upon warm- 
ing to 37°C, NF-rB-binding activity appeared in the nuclear 
fraction within 30 min. By contrast, nocodazole treatment 
led to rapid nuclear translocation of activated NF-KB, even 
though a significant portion of activated NF-KB remained in 
the cytoplasmic fraction. The cytoplasmic form of NF-KB is 
unlikely to be derived from leakage from the nucleus during 
cell fractionation since the p50 homodimer was exclusively 
nuclear under all conditions. Nocodazole illicited a stronger 
activation of NF-rB than cold depolymerization, and this 
difference is reflected in the extent of IrBot degradation (Fig. 
7  b;  quantitation  by  phosphorimage  analysis  indicated  a 
12-fold decrease in NOC-treated cells compared to fourfold 
decrease in cold treated cells after 60 rain of treatment). As 
expected, the effect of low temperature exposure on NF-rB 
activity correlates with its effect on microtubule integrity. 
Immunoblotting of Triton-soluble and -insoluble fractions 
using anti-~-tubulin antibody revealed considerable depoly- 
merization of microtubules within 30 rain of incubation at 
4°C and rapid recovery upon temperature upshift (data not 
shown). These results suggest that NF-~B activation in re- 
sponse to microtubule depoloymerization occurs in at least 
two steps. During the first step, NF-KB activation occurs in 
the cytoplasm, and during the second step, it is translocated 
to the nucleus. Since low temperature is likely to inhibit nu- 
clear transport, an energy- and temperature-dependent pro- 
cess (49,  54), it causes the accumulation of free NF-KB in 
the cytoplasm. Activation in the cytoplasm is consistent with 
our previous results, where irradiation with ultraviolet C was 
used to activate NF-~B in enucleated cells (21). 
Microtubule Depolymerization  Activates 
NF-r,B-dependent Gene Expression 
To examine whether the induction of NF-KB-DNA-binding 
activity in vitro correlates with increased NF-KB-dependent 
transcription in vivo, HeLa cells were transfected with a CAT 
reporter gene controlled by a truncated c-fos promoter up- 
stream to which two copies of the rB-binding site were in- 
serted, 2xxB-CAT. As shown in Fig. 8, nocodazole treatment 
stimulated CAT activity fourfold, while treatment with TPA 
resulted in a 8.5-fold stimulation of CAT activity. Nocoda- 
zole or TPA treatment did not induce expression of a CAT 
reporter containing two copies of a mutated version of the 
xB site upstream of the c-fos promoter, 2xmrB-CAT. As was 
shown in the mobility shift assays (see Fig. 3), nocodazole 
had no effect on expression of an AP-l-dependent reporter, 
-73Col-CAT (2), whereas TPA stimulated expression of this 
reporter fivefold (Fig. 8). These results are consistent with 
the  notion  that  micrombule  depolymerization  results  in 
specific activation of NF-KB-dependent gene expression. 
Discussion 
Over the years, many examples have been found that demon- 
strate a link between cell shape changes, the cytoskeleton, 
and alterations in the program of gene expression (6). How- 
ever,  the  signal  transduction  pathways  by  which  the  cy- 
toskeleton can influence gene expression have remained a 
mystery. The series of experiments described above demon- 
strate a  pathway by which a  major component of the cy- 
toskeleton, the microtubule network, can affect the nuclear 
transcriptional machinery by modulating the activity of a 
specific transcription factor. We show that a variety of agents 
and treatments that depolymerize microtubules cause rapid 
and efficient activation of the transcription factor NK-KB and 
The Journal of Cell Biology,  Volume 128, 1995  1116 Figure 7. Activation of NF-xB by cold shock. HeLa $3 cells were incubated in control medium at either 37°C (CON, 0 time point) or 
4°C, or in the presence of 0.4/zg/ml nocodazole (NOC) at 37°C for the indicated time periods (in minutes). An additional plate of cells 
was incubated at 4°C for 120 min and then shifted to 37°C for 30 min (4-37°C). Ceils were harvested, and cytoplasmic and nuclear extracts 
were prepared. (a) The level of NF-rB-binding activity was determined by mobility shift assays using nuclear extracts (5 #g) and cytoplas- 
mic extracts (derived from the same number of cell equivalents as 5 ttg of nuclear extract) and a radiolabeled palindromic NF-rB probe. 
The migration positions of the protein-DNA complexes formed by NF-rB, the p50 homodimer, and the nonspecific DNA binding protein 
(NS) are indicated. (b) The level of IrBc~  protein in the cytoplasmic extracts (15/~g/lane) was determined by immunoblot with an antiserum 
to IrBct. Only the portion of the autoradiogram corresponding to the IrBc~ band is shown. 
thereby activate transcription of NF-rB-responsive genes. 
Taxol, a microtubule-stabilizing agent, blocks the induction 
of NF-rB by microtubule-disrupting agents and/3-1umicol- 
chicine, an analogue of colchicine that does not disrupt mi- 
crotubules, does not activate NF-rB. These results strongly 
suggest that the observed induction is a direct and specific 
response  to  microtubule  depolymerization.  Treatment of 
cells with cytochalasin D, which causes depolymerization of 
actin filaments, did not result in effective NF-xB activation. 
Therefore, NF-rB activation is not caused by nonspecific and 
general  disruption  of the  cytoskeleton.  In  addition,  the 
DNA-binding activities of two other transcription factors, 
Spl and AP-1, were not affected by the state of microtubule 
polymerization. 
Figure 8. Nocodazole induces expression of an NF-rB--dependent 
reporter gene. HeLa $3 cells were transfected with the indicated 
reporter constructs, as described in Materials and Methods. The 
fold induction was calculated relative to the level of expression of 
each reporter in untreated cells. The nocodazole (NOC; 0.4 #g/ml) 
and TPA (100 ng/ml) treatments were for 12 h, and they were initi- 
ated 24 h after transfection. The results shown represent the aver- 
ages of four separate experiments for the 2xrB-CAT reporter and 
three experiments for the 2xmrB-CAT and -73 Col-CAT reporters 
that were used as controls. 
Microtubule-depolymerizing  agents  were  previously 
shown to induce the expression of at least two genes, coding 
for uPA (11, 38) and IL-I/3 (23, 44), both of which are also 
inducible by phorbol esters  and  inflammatory mediators, 
and are known to be regulated by NF-rB (29, 33). The mech- 
anism of uPA transcription of colchicine was shown to in- 
volve AP-1 (13), while its activation by phorbol ester involves 
NF-rB (29). We were not able to detect a considerable in- 
crease in  AP-l-binding  activity after microtubule depoly- 
merization (Fig. 3), but binding activity to an oligonucleo- 
tide corresponding to the NF-rB-binding  site in the uPA 
promoter (29) is induced to the same extent as the palin- 
dromic NF-rB-binding activity after nocodazole treatment 
(Rosette, C., unpublished result). The mechanism of IL-1/3 
induction by microtubule depolymerization is unknown, al- 
though NF-kB may certainly be involved. It was shown that 
colchicine induces the expression of IL-1/3 mRNA and pro- 
tein in human monocytes (23,  44), and we found that NF- 
rB-binding activity to an oligonucleotide corresponding to 
the NF-rB-binding site located in the IL-1/3 promoter (33) 
is induced in monocytes treated with colchicine (Fig. 4 c). 
Interestingly, IrBt~ was  cloned as a  rapidly induced tran- 
script in human monocytes after adherence (30), a cellular 
state that is accompanied by changes in the organization of 
the cytoskeletal network (8). 
In addition to phorbol esters, NF-xB activity is induced by 
TNF-ct,  IL-1,  bacterial  lipopolysaccharide,  and  in  a  few 
cases, by serum growth factors (reviewed in references 3, 28, 
39). It is of interest that all of these agents are known to in- 
duce reorganization of the cytoskeleton (1, 47).  Thus, it is 
possible that partial  or selective depolymerization of mi- 
crotubules by any of these agents could be an intermediate 
in the signaling pathway leading to activation of NF-KB, or 
act in synergy with other more conventional pathways, such 
as  the  activation  of yet-to-be identified  protein  kinases, 
thought to activate NF-xB through phosphorylation oflxB (3, 
39). So far, however, we found that pretreatment with taxol 
does not block the induction of NF-rB by either TPA (Fig. 
4  a),  TNF-c~, or serum (Rosette, C., unpublished results). 
Therefore, none of these signals appear to rely on microtu- 
bule reorganization. 
How does depolymerization of microtubules lead to acti- 
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TPA and TNF-ol (4,  12, 32, 58), microtubule disruption by 
drugs and by cold treatment lead to IKB degradation (Figs. 
4 b and 7 b). The critical step leading to I~B degradation may 
be its phosphorylation (Karin,  M.,  and T.  Hunter,  manu- 
script submitted for publication). Two protein kinases, MAP 
kinase (57) and protein kinase A (44) were shown to be acti- 
vated by colchicine.  The kinase that phosphorylates IxB in 
vivo has not been identified. Nevertheless, we find that incu- 
bation with the general protein kinase inhibitor, staurospo- 
rin, prevents the activation of NF-KB by nocodazole. Hence, 
a protein kinase may be involved in this signaling event as 
well. Alternatively,  degradation of I~B may be triggered by 
other  mechanisms,  such  as  ubiquitination.  Interestingly, 
ubiquitin and ubiquitin activating enzyme  are localized  to 
microtubules  (48,  59).  Whatever  the  mechanism  of  IKB 
degradation, our observations that the level of NF-KB-bind- 
ins activity induced by microtubule-disrupting drugs and by 
cold treatment correlates well with the degree of IKBo~ disap- 
pearance and that resuppression of NF-KB-binding activity 
upon  microtubule  repolymerization  is  dependent  on  new 
protein synthesis, suggest it is likely regulated by changes in 
IKB level. 
Although the exact biochemical process by which depoly- 
merization of microtubules leads to activation of NF-KB re- 
mains to be elucidated, the present findings establish a role 
for NK-~B in sensing changes in the state of the cytoskeleton 
and converting them to changes in gene activity. While the 
present work has relied on agents and treatments that cause 
general  depolymerization  of microtubules,  it is likely  that 
NF-~B and related transcription factors may actually become 
activated  in  response  to  depolymerization  of a  small  and 
specific subset of the entire microtubule network. Since such 
cytoskeletal  changes are likely  to be induced by cell-sub- 
strate and cell-cell  interactions, this process would provide 
a signal transduction pathway by which these physical inter- 
actions can modulate gene expression and thereby affect the 
differentiated phenotype. 
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